The consent process should allow for an exchange of information between the investigator and the subject, and afford ample opportunity for the subject to ask questions and consider whether or not to participate in the study. In most cases the federal regulations require that informed consent be documented. It should be reiterated, however, that the consent document does not substitute for discussion.

Informed Consent Process

Jump to: 

Documenting Consent Re-consenting or Notifying Posting Consent Forms OHRP FAQs

 

Consent Discussion Process 

The consent process should allow for an exchange of information between the investigator and the subject. Even the best document is no substitute for two-way communication, interaction, and listening.

  • For complex or detailed studies, consider sending information and consent document in advance to allow potential participant time to review and think of questions.
  • Introduce yourself and take time to ask questions to assess prospective participant’s knowledge, experience, frame of mind, health literacy, motives, etc.
  • Actively listen!
  • Use plain language.  Be specific and concreate in communication.
  • Clarify what is and what is not part of the research (e.g., what will occur regardless of their participation such as standard of care procedures).
  • Describe foreign or technical concepts.
  • Use visual aids, glossary of terms, video or audio, illustrations, models or samples of interventional products. 
  • Provide foundational education as needed (e.g., what is disease and standard treatment; what is a clinical trial, research purpose you are partnering with them to discover or solve)
  • If you are treatment provider, clarify that this is “research” to prevent therapeutic misconception.
  • If you are in a position of authority, reiterate that participation is totally voluntary and withdrawal is always an option (e.g., teachers, employers).
  • Use teach-back open-ended questions to assess understanding and clarify misperceptions.
  • After the study, evaluate your process by asking participant what they wish they would have known.

Documenting the Informed Consent Process

Include the following:

  • Statement that “eligibility criteria met” (or completed eligibility checklist attached);
  • Date;
  • Details of who involved/present;
  • Description of process;
  • Discussion items;
  • Questions & clarifications;
  • Any assessment used to document understanding;
  • Statement that subject voluntarily consented to participate prior to participating;
  • Copy of signed consent given to subject;
  • Any other pertinent information (witness, LAR, supplemental materials); 
  • PI contact information;
  • IRB number;
  • Protocol title;
  • Version of the consent document signed.

Samples (Please note: These may not suit your protocol precisely, however, they may serve as a guide to get you started):

  • Template for History/Progress Note in Medical Record (UK) [PDF]
  • Researcher's Certification of Consent and Authorization (AHRQ) [PDF]

Re-consenting or Notifying Participants

Would you ever need to re-consent a research participant? [D100.0000] [PDF]

Future Research Use

Posting Federally Funded Clinical Trial Consent Forms [D151.0000]
OHRP Frequently Asked Questions on Informed Consent